Sign in

CIK 0001137883

  • Non-accelerated filer
  • Smaller reporting company

BRAINSTORM CELL THERAPEUTICS INC.

Sign in to watch
Ticker
BCLI
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
207273918
Phone
+1 201-488-0460
Business address
1325 AVENUE OF AMERICAS, 28TH FLOOR, NEW YORK, NY, 10019
Former names
BRAINSTORM CELL THERAPEUTICS INC, GOLDEN HAND RESOURCES INC, WIZBANG TECHNOLOGIES INC
  1. 4 Open-market sale Director sold 168,000 shares at $0.30 ($50,400)
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 3 Insider Initial Statement of Ownership
  5. 4 Open-market sale Director sold 5,000 shares at $0.30 ($1,500)
  6. 4 Open-market sale Director sold 104,466 shares at an average $0.30 ($31,448)
  7. 4 Open-market sale Director sold 27,354 shares at $0.30 ($8,206)
  8. 4 Open-market sale Director sold 43,630 shares at $0.30 ($13,089)
  9. 4 Open-market sale Director sold 40,400 shares at $0.31 ($12,322)
  10. 4 Open-market sale Director sold 50,000 shares at $0.31 ($15,500)
  11. 4 Open-market sale Director sold 131,468 shares at an average $0.32 ($41,830)
  12. 3 Insider Initial Statement of Ownership
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 4 Open-market sale Director sold 575,000 shares at an average $0.26 ($147,098)
  16. 4 Open-market sale Director sold 200,000 shares at an average $0.29 ($58,290)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 3 Insider Initial Statement of Ownership

Page 13 of 17 · 329 filings